Perspective on the current use of bortezomib in multiple myeloma.
San-Miguel
Jesús
J
Bladé
Joan
J
D001897:Boronic Acids / Q000627:therapeutic use* / Q000633:toxicity; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use* / Q000633:toxicity
D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib